Swiss Re discussed investing in Anbang Insurance Group Co., Bloomberg reported on Friday. According to the report, although the insurer talked to Chinese officials, it hasn’t made a final decision about making an investment. The report comes after the outlet reported that Singapore’s state-run investment firm Temasek held discussions about buying a stake in the Beijing-based company. That report detailed, however, that Temasek is not in any active negotiations with Anbang.
The Trump administration asked the Ninth Circuit on Friday to lift a nationwide ban on new rules that exempt employers with moral or religious objections from providing birth control coverage otherwise required by the Affordable Care Act, saying employers’ First Amendment rights should trounce procedural requirements for passing the new regulations.
A major U.S. dental supply company has accused the Federal Trade Commission of "severe hindsight bias" in the commission's suit alleging three suppliers conspired to spurn buying groups, asking an administrative law judge to toss the agency's action.
A majority of New York state’s highest court has agreed that a portion of the state Department of Health's restriction on how much certain health care executives of providers contracting with the state can get paid went beyond the state’s authority.
In the first week of a trial in Massachusetts federal court for six former employees of the New England Compounding Center, whose contaminated drugs sparked a deadly meningitis outbreak in 2012, the question of who bears responsibility for fake patient names used on prescription order forms has been a daily point of contention.
DJO Global Inc.'s medical walking boots cause additional injuries by effectively lengthening one leg, giving wearers an uneven gait and throwing their bodies out of alignment, according to a proposed class action filed in California federal court.
The University of Southern California announced Friday it reached a $215 million deal in principle to resolve a proposed class action accusing a former staff gynecologist of sexually abusing potentially thousands of women.
Within the next year, the Employee Benefits Security Administration hopes to make association retirement plans a reality, clarify what comes after the fiduciary rule and allow employers to stop covering workers’ birth control by claiming a moral or religious objection to its use.
An Eisai Inc. sales representative downplayed the potential for epilepsy drug Fycompa to make patients think about killing people and promoted the product for off-label uses, the U.S. Food and Drug Administration said in a disciplinary letter released Wednesday.
A Pittsburgh-area pharmacy services provider that lost two executives to a rival was rightly denied a preliminary injunction against its competitor because the “irreparable harm” it sought to stop could be quantified and covered by damages, a Pennsylvania Superior Court panel ruled Thursday.
An Arkansas ballot issue aiming to institute sweeping tort reforms in personal injury lawsuits, including caps on certain damages and attorneys’ fees, will not be presented to voters next month after the Arkansas Supreme Court ruled Thursday that the measure was unconstitutional.
MPX Bioceutical Corp. and iAnthus Capital Holdings Inc. said Thursday they have agreed to the terms of a merger that will see the cannabis firms combine in an all-stock transaction with an offered equity consideration to MPX shareholders valued at CA$835 million ($638.3 million), a deal guided by McMillan LLP.
Horizon Healthcare Services Inc. and CentraState Medical Center Inc. on Thursday announced that they have resolved CentraState's claims in a New Jersey state lawsuit alleging that the insurer's tiered health coverage plan left certain hospitals competitively disadvantaged, leaving only one hospital taking the company to trial next week.
A prosecutor wearing purple protective gloves in Massachusetts federal court on Thursday presented a series of apparently expired drugs seized from the New England Compounding Center in 2012 as the government tried to build its case that the facility's operations were sloppy and unsafe before a deadly meningitis outbreak that killed dozens of people.
Hinshaw & Culbertson LLP has added a former Wilson Elser Moskowitz Edelman & Dicker LLP attorney as a health care partner in its Miami office, with the aim of helping its national practice group offer clients support in the state and expanding its work in a number of growth areas in the industry.
Horizon Healthcare Services Inc. has sought to disqualify DLA Piper LLP from representing a group of specialty pharmaceutical companies who sued Horizon for allegedly refusing to pay for health plan members' hemophilia treatments, arguing that the law firm was still representing Horizon when it decided to take the case.
Blue Cross Blue Shield insurers facing long-running multidistrict litigation over an alleged conspiracy to divvy up the market are protected by prior settlement agreements that free them from the claims, even though they never signed the deals, an Alabama federal judge ruled Wednesday.
A proposed class of American workers who received psychotherapy through their employers’ health care plans sued United Healthcare Insurance Co. and United Behavioral Health in California federal court Tuesday, accusing them of flouting the Employee Retirement Income Security Act by imposing unfair reimbursement limits on psychotherapy services.
After an emotionally fraught confirmation process with sexual misconduct allegations front and center, a new justice joins the Supreme Court bench and brings four female clerks with him. The hires bring gender parity to the court's clerkship ranks for the first time, but will the shift be long-lasting?
Criminal forfeiture law prevents False Claims Act whistleblowers from intervening in related forfeiture proceedings when the government chooses prosecution over intervening in a related FCA case, the Eleventh Circuit ruled Wednesday.
The process of applying for litigation financing isn’t difficult, but few do it right the first time. Following five steps in your application process will help make sure litigation funders are convinced of the value of your company's legal claims, says Molly Pease of Curiam Capital LLC.
A U.S. Supreme Court ruling in Varela v. Lamps Plus that the Federal Arbitration Act displaces contractual interpretation rules likely would vacate the Eleventh Circuit's recent JPay decision, says James Bogan of Kilpatrick Townsend & Stockton LLP.
The U.S. Supreme Court recently agreed to review the D.C. Circuit's decision in Allina Health Services v. Azar, which has the potential to resolve the issue of whether or not the Medicare Act requires notice-and-comment rule-making in more situations than are required by the Administrative Procedure Act, says Robert Wanerman of Epstein Becker Green.
In an era when law firms are fighting for business and clients can dictate the terms of the relationship, "value" has become a moving target. Firms that take a proactive approach by using strategies designed to articulate value over time will gain the competitive advantage, says Dan Tacone at Intapp Inc.
Blockchain-powered tools may revolutionize health care by allowing providers to easily exchange medical and health records while still protecting patients' information, but entrepreneurs must carefully consider novel legal challenges and questions, say Jonathan Gordon and Jesse Welsh-Keyser of Alston & Bird LLP.
In this monthly series, Amanda Brady of Major Lindsey & Africa interviews management from top law firms about the increasingly competitive business environment. Here we feature Pier D'Angelo, chief pricing and practice officer at Allens.
In the two years since the American Bar Association's controversial anti-discrimination and harassment rule, only one state has adopted it, while numerous state supreme courts, state attorneys general and legal groups have correctly rejected Model Rule 8.4(g) as a threat to lawyers' First Amendment rights, says Bradley Abramson, an attorney with Alliance Defending Freedom.
In the aftermath of Justice Brett Kavanaugh's confirmation, the U.S. Supreme Court should decline review of the nation's most polarizing political questions unless and until the questions become time-sensitive, says Alexander Klein, head of the commercial litigation group at Barket Epstein Kearon Aldea & LoTurco LLP.
In this series featuring law school luminaries, Boston College Law School professor Kent Greenfield reflects on his corporate law theories, his legal battle with the Pentagon over free speech and gay rights, and important constitutional law issues to watch out for.
Many describe "price transparency" as the solution to what is wrong with health care, but the reality may well be that transparency is only a stepping stone to actual price controls. Recent events illustrate the range of avenues being pursued as legislators address the cost of health care, say Mark Waxman and Kristin Jenkins of Foley & Lardner LLP.